Thank you for being one of our most loyal readers. Please consider supporting community journalism by subscribing to The Wilson Times.
Fresenius Kabi will expand its manufacturing operations in Wilson County, adding 445 jobs over the next five years, Gov. Roy Cooper announced Tuesday.
The expansion project will be a $150 million investment to Wilson, local officials said.
Fresenius Kabi, which currently employs more than 100 people in Wilson, is a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition.
“I’m proud that North Carolina is home to so many strong life sciences companies that make life-saving medicines,” Cooper said in a statement. “This expansion is welcome news for eastern North Carolina and our entire state and shows once again that manufacturing thrives in North Carolina today.”
Fresenius Kabi’s plans in North Carolina include expansion of its current pharmaceutical production facility in Wilson and the construction of a new manufacturing facility, also in Wilson. Both sites will be dedicated to manufacturing products used in hospitals and clinics throughout the United States and Canada.
Fresenius Kabi has owned its Wilson site on Corporate Parkway, which specializes in the production of ready-to-administer syringes, since January 2016.
“Our strategy is to produce in the U.S. and to invest in products and operations that meet important customer needs while helping make health care more accessible for patients. We’re pleased to continue this approach at our site in North Carolina,” Steven R. Nowicki, senior vice president of global operations for Fresenius Kabi North America, said in a release.
MORE THAN A YEAR IN THE WORKS
The project was announced during a Wilson County commissioners meeting in October, although the name of the company wasn’t released until Tuesday.
Fresenius Kabi will add a variety of jobs with the expansion, including production specialists, engineers, scientists and managers.
The average salary for jobs will be in the upper tier for Wilson, which is $60,000 per year or more, local officials said in October.
“The Wilson Economic Development Council has been working with Fresenius Kabi for over a year on the expansion of its current plant and the new plant location,” said Jennifer Lantz of the Wilson Economic Development Council. “We are excited about the new jobs being created and the growth in our life science sector.”
Lantz said the expansion would not have been possible without Wilson County, the city of Wilson and Wilson on the Move.
Wilson County Manager Denise Stinagle said it was exciting news for Wilson County residents and the local economy.
“We are pleased that Fresenius Kabi recognizes the valuable asset of Wilson County’s workforce and the collaborative efforts of economic development and many partners,” Stinagle said.
Assistant County Manager Ron Hunt said officials will continue their collaborative efforts to put Wilson County’s best foot forward.
“Supporting job growth and becoming a choice for companies to locate and expand is part of this,” Hunt said.
Fresenius Kabi’s expansion in Wilson County will be facilitated, in part, by a Job Development Investment Grant approved by the state’s Economic Investment Committee earlier Tuesday. Over the course of the 12-year term of this grant, the project will grow the state’s economy by an estimated $853 million, state officials said.
“Manufacturing represents 22 percent of our state’s economic output, and we’re one of the country’s largest centers for biotechnology,” N.C. Commerce Secretary Anthony M. Copeland said in a statement. “We congratulate Fresenius Kabi for this decision, which helps North Carolina maintain its leadership in manufacturing and the life sciences.”
Fresenius Kabi recently broke ground on a $250 million expansion at its pharmaceutical manufacturing site in Melrose Park, Illinois. In total, the company employs more than 3,000 people in the U.S., and its U.S. headquarters is in Lake Zurich, Illinois. Fresenius Kabi’s global headquarters is in Bad Homburg, Germany.